Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Deal adds 100+ pharmacovigilance technology experts and strengthens capabilities across Veeva, Oracle Argus, and ArisGlobal platforms.
October 6, 2026
By: Charlie Sternberg
Biomapas, an integrated life sciences services provider, has acquired Pinnaxis, a Noida, India-based global pharmacovigilance technology and consulting company. Pinnaxis specializes in safety system implementation and upgrades, data migration, system integration, validation, reporting and analytics, and managed services.
The acquisition strengthens Biomapas’ drug safety technology capabilities by adding engineering and configuration expertise across major safety platforms, including Veeva Safety Vault, Oracle Argus, and ArisGlobal, as well as established relationships with the safety database providers. Pinnaxis also adds more than 100 technical experts and proprietary tools and accelerators for safety data migration, reporting, and case intake automation.
Pinnaxis will lead Biomapas’ Consulting & Digital business unit, shaping the company’s use of technology and innovation across its services, including greater adoption of automation and AI in routine safety work. The acquisition also expands Biomapas’ U.S. presence through Pinnaxis’ established client base and New Jersey office, supporting the group’s plans to grow its North American business.
Nishant Rana, Founder & CEO of Pinnaxis, said, “Joining Biomapas is a major strategic move for Pinnaxis, our team and our clients. We have built a business with deep expertise in safety systems, and becoming part of a broader life sciences platform lets us take that further, reaching clients across Europe and beyond and offering them more than technology alone.”
Xavier Duburcq, CEO of Biomapas, said, “Pinnaxis brings deep expertise in the technology behind drug safety, strengthening our ability to connect specialist services with the systems that support them. Together with our regulatory, safety and clinical teams, we will help clients manage increasingly complex requirements across the product lifecycle, combining scientific expertise with technology.”
Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
